ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $39 | -87.9% | 187 | -79.7% | 0.00% | – |
Q1 2023 | $322 | +63.5% | 919 | +0.3% | 0.00% | – |
Q4 2022 | $197 | – | 916 | -8.9% | 0.00% | – |
Q3 2022 | $0 | -100.0% | 1,005 | +0.9% | 0.00% | – |
Q2 2022 | $1,000 | -50.0% | 996 | +2.9% | 0.00% | – |
Q1 2022 | $2,000 | 0.0% | 968 | +11.9% | 0.00% | – |
Q4 2021 | $2,000 | -33.3% | 865 | 0.0% | 0.00% | – |
Q3 2021 | $3,000 | +50.0% | 865 | +5.1% | 0.00% | – |
Q2 2021 | $2,000 | 0.0% | 823 | +1.9% | 0.00% | – |
Q1 2021 | $2,000 | +100.0% | 808 | +0.4% | 0.00% | – |
Q4 2020 | $1,000 | -50.0% | 805 | +0.8% | 0.00% | – |
Q3 2020 | $2,000 | +100.0% | 799 | +1.0% | 0.00% | – |
Q2 2020 | $1,000 | 0.0% | 791 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | -50.0% | 791 | +5.5% | 0.00% | – |
Q4 2019 | $2,000 | +100.0% | 750 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 750 | +15.4% | 0.00% | – |
Q2 2019 | $1,000 | -50.0% | 650 | 0.0% | 0.00% | – |
Q1 2019 | $2,000 | +100.0% | 650 | +160.0% | 0.00% | – |
Q4 2018 | $1,000 | – | 250 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VANGUARD GROUP INC | 38,982 | $200,000 | 0.00% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 802 | $5,000 | 0.00% |
UBS Group AG | 2,723 | $14,000 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 11,775 | $60,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 250 | $1,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 27,162 | $138,000 | 0.00% |
MORGAN STANLEY | 545 | $3,000 | 0.00% |
BlackRock Inc. | 205,684 | $1,053,000 | 0.00% |